US2010297732A1PendingUtilityA1

Vectors with modified protease-dependent tropism

47
Assignee: DNAVEC RESEARCH INCPriority: Apr 30, 2002Filed: Feb 25, 2010Published: Nov 25, 2010
Est. expiryApr 30, 2022(expired)· nominal 20-yr term from priority
A61P 35/00C12N 2760/18022A61K 48/00C12N 15/86C12N 2800/30C07K 2319/50C12N 2760/18822C12N 2760/18843C07K 14/005A61K 38/00C12N 7/00C12N 15/11C12N 15/82C07K 14/115
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides cell fusogenic vectors having replicative ability, whose protease-dependent tropism has been modified. M gene-deficient viral vectors encoding modified F proteins, in which the cleavage site of the F protein of paramyxovirus is modified to be cleaved by different proteases, were produced. In cells transfected with these vectors, the genomic RNA present in the vectors is replicated, and cell fusogenic infection spreads to neighboring cells depending on the presence of other proteases; however, no viral particles are released. The vectors of this invention, encoding the F proteins which are cleaved by proteases whose activity is enhanced in cancer, show cancer growth suppressive effect in vivo.

Claims

exact text as granted — not AI-modified
1 . A nucleic acid encoding a recombinant modified paramyxoviral F protein comprising Pro-Leu-Gly, Pro-Gln-Gly, or Val-Gly-Arg at the cleavage site, wherein the modified paramyxoviral F protein shows cell fusogenicity in the presence of a matrix metalloproteinase or a plasminogen activator. 
     
     
         2 . A viral particle comprising the nucleic acid of  claim 1 .

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.